IL6 and ischemic stroke: In conclusion, this study indicated that IL-6 preconditioning successfully enhanced the therapeutic potential of NSCs for ischemic stroke by increasing anti-oxidant activities, improving the survival rate of grafted cells, inducing their integration into the impaired neuronal networks, and elevating angiogenesis after ischemic stroke injury.